Periodic Reporting for period 1 - PANACEA (PracticAl and Effective tools to moNitor and Assess CommErciAl drivers’ fitness to drive)
Période du rapport: 2021-05-01 au 2022-10-31
The project will design, develop and test a holistic driving ability assessment system for commercial drivers to be used pre-driving, during driving and at the roadside, paired with cloud-based countermeasure and coaching solutions. In order to achieve this, PANACEA
will create driver-oriented, health-based, touchless, and Use Case (UC) driven health monitoring and assessment solutions capable of detecting alcohol, licit (barbituric), illicit (methadone replacement) drugs, fatigue, stress, and cognitive load. Those drivers detected as unfit by the assessment/monitoring technology will receive personalised, targeted support from the cloud-based countermeasure and coaching system. Commercial Health Toolkits (CHTs), combining assessment/monitoring techniques with countermeasure solutions, will be tailored to fit the specific needs of each UC. The CHTs aim to become an ecosystem of support and knowledge for drivers and operators alike, available before/after/during shifts as well as on site and roadside. The sensitivity, specificity, robustness, ease-ofuse, satisfaction and acceptance of these CHTs will be evaluated with over 90 AV shuttle, e-truck, coach and taxi drivers and courier service riders, operators and stakeholders, across 3 UC-driven Pilots (Greece, Spain and Sweden),
considering gender specificities. A 4th UC focus on the transferability of the improved knowledge and technologies to other transport modes (i.e. aviation, maritime and rail). The primary outcome of PANACEA is the creation of new assessment technologies and countermeasure strategies which come together as a new fitness to drive paradigm
applicable in commercial vehicle operations with vehicles at various automation levels. Finally, with the support of the Advisory Board, policy and legislative recommendations and updates of existing standards for health provision for commercial transportations will be provided.
will create driver-oriented, health-based, touchless, and Use Case (UC) driven health monitoring and assessment solutions capable of detecting alcohol, licit (barbituric), illicit (methadone replacement) drugs, fatigue, stress, and cognitive load. Those drivers detected as unfit by the assessment/monitoring technology will receive personalised, targeted support from the cloud-based countermeasure and coaching system. Commercial Health Toolkits (CHTs), combining assessment/monitoring techniques with countermeasure solutions, will be tailored to fit the specific needs of each UC. The CHTs aim to become an ecosystem of support and knowledge for drivers and operators alike, available before/after/during shifts as well as on site and roadside. The sensitivity, specificity, robustness, ease-ofuse, satisfaction and acceptance of these CHTs will be evaluated with over 90 AV shuttle, e-truck, coach and taxi drivers and courier service riders, operators and stakeholders, across 3 UC-driven Pilots (Greece, Spain and Sweden),
considering gender specificities. A 4th UC focus on the transferability of the improved knowledge and technologies to other transport modes (i.e. aviation, maritime and rail). The primary outcome of PANACEA is the creation of new assessment technologies and countermeasure strategies which come together as a new fitness to drive paradigm
applicable in commercial vehicle operations with vehicles at various automation levels. Finally, with the support of the Advisory Board, policy and legislative recommendations and updates of existing standards for health provision for commercial transportations will be provided.
After 18 months the technical and functional specifications, the PANACEA platform modalities, the CHTs per Use Case have been defined in (WP2), the data characteristics and thresholds have been defined in WP3 and the integration process has been progressing (WP4). In addition, the technical verification and validation process is started based on the steps and templates described (WP4). Data on sensitivity, specificity, and accuracy (where exists) of each technology in the CHTs and the relevant state-of-the-art in the field of each technology have been gathered (WP3) and a decisions was made to strive to use other more suitable metrics taking also the integration of sensor into consideration. The cloud bases countermeasure system has been defined in WP5 and are under development and the evaluation framework is defined in (WP6). Data collection supporting WP3 development is formulated and partly even done. Data collection at roadside, by the police in Norway, has been done evaluating the alco sensor in real operational settings on almost 600 drivers. The status in the three UC driven pilots is on integration finalisation stage. The primary outcome of PANACEA is the creation of new assessment technologies and countermeasure strategies which come together as a new fitness to drive paradigm applicable in commercial vehicle operations with vehicles at various automation levels are seen as achievable.
Refer to the main technical report: First periodic technical report